Experiences with
Immunomodulation9 public posts
Persisting symptoms in patients with Hashimoto’s disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? A sys
To prove causality, a necessary next step is to design and conduct intervention studies, for example immunomodulation vs. placebo preferably in the form of a randomized controlled trial, with symptoms and QoL as main outcomes.
Want to take advantage of all our features? Just log in!
or
Lupus Researchers Uncover New Target to Prevent Vascular Complications in Certain Patients
“APS is an autoimmune disorder that is still primarily treated with anticoagulation, rather than immunomodulation,” authors wrote, but added that due to the inherent risk of anticoagulation treatment for APS, other treatment approaches should be pursued.
Novel Biologic Agents for Non-HL and CLL — Part 2: Adoptive Cellular Immunotherapy, Small-Molecule Inhibitors, and Immunomodulation
"[/i]
* Chimeric antigen receptor (CAR) T cells
* Bruton tyrosine kinase (BTK) inhibitors (Ibrutinib)
* PI3K delta inhibitors (Idelalisib, Duvelisib (IPI-145), TGR-1202, )
* BCL-2 family inhibitors (Navitoclax (ABT-263), ABT-199
* Immunomodulation (Lenalidomide)
* Other Novel Therapies
Small Molecules